Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Defendants of the case MYDX filed for dismissal? The case the company sued for $29,000,000.00 and got a $5k settlement from someone who, according to court records, wasn’t even represented by a lawyer.
And was dismissed in 2018?
That case?
Mighty bold lies told about MYDX have mortally wounded the company. Such as product releases which never happened, which led to the SP nosediving from $3.00 to $0.000001. Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
Another 30M no-bid MYDX shares sold today in value restoration.
Oh, and speaking of attorneys in this case, did you see that Yazbeck brought back Lendon Webb? He’s the attorney who filed the case against Dewald and Sanzeri for $29,000,000.00, but Yazbeck only got that $5K.
But Webb, according to court website, departed the case prior to MYDX filing for dismissal. Yazbeck filed for attorney substitution six weeks prior to filing for dismissal of lawsuit in 2018.
LOL, the MYDX story is STILL about a case the company filed in 2017 and ended up filing for dismissal in 2018.
The company sued for $29,000,000.00 and ended up settling for $5K from a defendant who, according to the court website, had no legal representation.
And the other defendant? Owed nothing to MYDX.
MYDX filed for dismissal of its own lawsuit back in 2018. LOL
Is this the lawsuit MYDX filed for dismissal two years ago, in 2018?
Mighty big losses to those who bought MYDX at .0185, which with Thursday’s close put losses at 99.96%.
LOL, the MYDX story is STILL about a case the company filed in 2017 and ended up filing for dismissal in 2018.
The company sued for $29,000,000.00 and ended up settling for $5K from a defendant who, according to the court website, had no legal representation.
And the other defendant? Owed nothing to MYDX.
MYDX filed for dismissal of its own lawsuit back in 2018. LOL
Oddly enough, Erai Beckmann has also disappeared from the MYDX radar. Difference being, Beckmann got hundreds of thousands of dollars of MYDX Shareholder money to advise, promote and market a product the company has never released.
Mighty big losses to those who bought MYDX at .0185, which with Thursday’s close put losses at 99.96%.
Right. Same way Yazbeck “forgot” to release AeroDX, AquaDX, OrganaDX, the vape pen, the Israeli clinical trial results and the Canadian medical designation.
Yeah, wonder what else Yazbeck is hiding by not releasing financials anymore.
Mighty bold lies told about MYDX have mortally wounded the company. Such as product releases which never happened, which led to the SP nosediving from $3.00 to $0.000001. Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
LOL, what price action? The MYDX SP has been going from .000001 to .0001 with regularity.
Mighty bold lies told about MYDX have mortally wounded the company. Such as product releases which never happened, which led to the SP nosediving from $3.00 to $0.000001. Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
Peatross' complaint against Yazbeck accuses him of using Dr. Jess funds to fund his other business ventures. If Peatross has evidence Yazbeck used Dr. Jess funds to run MYDX business, it's not just Peatross' lawsuit that could land Yazbeck in trouble, it also puts MYDX's SEC filings into question.
It's unlikely the case will ever get heard as civil courts encourage mediation and resolution prior to any case making it to trial. Not to mention Yazbeck won't like being asked detailed, specific questions about MYDX while under oath.
Yazbeck is due in court May 7, 2021 involving MYDX’s former Chief Medical Officer, Jessica Peatross.
Highly doubtful it will go to trial since the deposition and cross-examination would likely involve Yazbeck answering questions about MYDX business under oath.
Last monthly report from the Transfer Agent from May 29, 2020 says 6,021,803,220 shares (2,002,467,377 restricted, 4,019,335,843 unrestricted) are in the OS.
According to the Form 4 received on May 8, 2018, Yazbeck has 1,789,351,606 shares of beneficial ownership from that conversion alone. That's probably on top of whatever shares YCIG has from other arrangements.
And these warrants are due in 35 days....
On July 30, 2018, the Company entered into a Settlement Agreement and Mutual Release with Torque Research & Development, Inc. (the “TRD Settlement”). Pursuant to the TRD Settlement, the parties agreed to terminate the February 8, 2017 Research & Development Agreement and the February 8, 2017 Exclusive License Agreement. In return for a full release by Torque Research & Development, Inc. (“TRD”), the Company to eventually issue 45,355 shares of Series B Preferred at a value of $1.00 per Series B Preferred share. The shares of Series B Preferred will be issued upon an increase in the authorized shares of Series B Preferred. The Company also agreed to issue a 7.5% Warrant with an expiration date of July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B Preferred shares and therefore, have recorded them as a liability at their fair value of $1,587,425.
On July 31, 2018, the Company entered into a Settlement Agreement and Mutual Release with BCI Advisors (the “BCI Settlement”). Pursuant to the BCI Settlement, the parties agreed to terminate the December 1, 2016 Advisory Services Agreement. In return for a full release by BCI, the Company agreed to eventually issue 38,272 shares of Series B Preferred at a value of $1.00 per Series B Preferred share. The shares of Series B Preferred will be issued upon an increase in the authorized shares of Series B Preferred. The Company also agreed to the assignment or issuance of three 7.5% Warrants. The Company agreed to the assignment of one previously issued 7.5% Warrant to an entity related to BCI Advisors. This 7.5% Warrant will expire on July 31, 2020. In addition, the Company also agreed to the assignment of another previously issued 7.5% Warrant to an entity related to BCI Advisors and agreed to extend the expiration date from March 1, 2019 to July 31, 2020. Finally, the Company agreed to issue a new 7.5% Warrant which will expire on July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B Preferred shares and therefore, have recorded them as a liability at their fair value of $1,262,976.
It’ll probably be the SEC knocking on Yazbeck’s door sooner than later.
LOL, “Yasbeck” is still working on OrganaDX, which has been coming soon since 2015.
Company still owes AQS $15K/month and Yazbeck’s salary of $10K/month.
How do they get out from under that dilution and make money to invest in itself on top of the $40 million deficit?
And the company is five weeks away from owing two companies $3 million for warrants they can’t satisfy because the company is maxed out in shares.
And the company is delinquent in reporting, to both the SEC and the state of Nevada. According to Rule 144, means they cannot adjust their OS.
How MYDX survives is beyond any logic.
Yup, 13.6M of 14.2M are sells.
LOL.....volume back.
LOL, the application that was allegedly filed by MYDX but was never affirmed in any SEC filings?
That one? Allegedly filed in 2017.
Three years now, LOL.
LOL.....that video is six years old.
It says right there in the YouTube video information MYDX out there itself, it’s from Vice’s Season 4, Episode 6.
Vice season 4 was produced in 2014.
And that MYDX CEO is the one who sued those two for $29,000,000.00 and had to settle for $5k from a defendant who, according to the court website, had zero legal representation.
Yazbeck filed for dismissal immediately afterward. LOL
MYDX Shareholders are down 99% in their investment. From $3.00 to $0.000001.
LOL....$22.00 in trades on Friday for MYDX.
Mighty bold lies told about MYDX have mortally wounded the company. Such as product releases which never happened, which led to the SP nosediving from $3.00 to $0.000001. Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
That's an awful lot of supposition there.
Why does GRWG have transparency problems?
Today I seen a few big blocks of 22700 shares and grwg went right though it in a few minutes time .
How is that known? Once again the company trumpets the purchase of another store, talks about the potential revenue, but does not disclose the purchase price.
Huh? What does this mean?
Mighty bold lies told about MYDX have mortally wounded the company. Such as product releases which never happened, which led to the SP nosediving from $3.00 to $0.000001.
Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
I’m personally not seeing dilution here... at least at any real measurable rate...
if you’re looking for dilution look for declining accumulation...
if you look around you’ll see the signs of dilution at other MJ co’s... the PINKY style dilution... and atm I’ll say I don’t see it like that here...
PLNHF finally did its inevitable cash raise.
Source
Not sure the $10M CAD ($7.4M USD) will be enough given they’re moving ahead with Santa Ana.
Next Q will show the COVID pain, then will get a better idea on how much more cash the company will need.
LOL, no it’s not.
MYDX hasn’t filed a 10-Q or filed its annual report with the State of Nevada either, now over half a year overdue.
MYDelinquentX.
How will shareholder value be restored when the company no longer files SEC mandated reports or the director’s report in Nevada?
Seems Like they are getting rewarded for increasing shareholder value huh?
Lampert and Salaman each got another 162,237 freshly printed GRWG shares per their employment agreement on April 1.
Value was over half a million then, now $1.2M today each. And that’s just their 2019 bonus.
Not a bad deal for simply buying up shops across the country and positioning the acquisitions as increased company revenue.
Gotham Green is selling more GRWG shares again, huh?
“Again” because look back in February 2020 and see how much they sold.
LOL, uh....no.
You’d think people who want to invest in MYDX want to know more about the company through its financials. Yet when they look for them, they can’t find them since MYDX has withheld its last 10-K and 10-Q.
The IR section no longer exists on the MYDX website either.
It’s almost as if the company doesn’t want people to know the company’s financials. I wonder why that is?